Liver Non-Hodgkin Lymphoma — Trials

Liver Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

69 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: City of Hope Medical Center
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04795869	Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma	withdrawn	Phase 2	0	Northwestern UniversityOTHER	1	Oct 10, 2023	clinicaltrials
NCT01652014	Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies	withdrawn	Phase 2	0	University of Medicine and Dentistry of New JerseyOTHER	1	Jul 14, 2016	clinicaltrials